PL4119573T3 - Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie - Google Patents

Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie

Info

Publication number
PL4119573T3
PL4119573T3 PL22744363.7T PL22744363T PL4119573T3 PL 4119573 T3 PL4119573 T3 PL 4119573T3 PL 22744363 T PL22744363 T PL 22744363T PL 4119573 T3 PL4119573 T3 PL 4119573T3
Authority
PL
Poland
Prior art keywords
preparation
application
recombinant human
human type
type xvii
Prior art date
Application number
PL22744363.7T
Other languages
English (en)
Inventor
Jiajia Li
Liping Wang
Song QIAN
Original Assignee
Jiangsu Trautec Medical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Trautec Medical Technology Co., Ltd. filed Critical Jiangsu Trautec Medical Technology Co., Ltd.
Publication of PL4119573T3 publication Critical patent/PL4119573T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281—Proteins, e.g. gelatin or collagen
    • A23L29/284—Gelatin; Collagen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/102—Plasmid DNA for yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/84—Pichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dispersion Chemistry (AREA)
PL22744363.7T 2021-05-13 2022-01-14 Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie PL4119573T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110520499.9A CN113185604B (zh) 2021-05-13 2021-05-13 一种重组人xvii型胶原蛋白、制备方法和应用
PCT/CN2022/071968 WO2022237224A1 (zh) 2021-05-13 2022-01-14 一种重组人xvii型胶原蛋白、制备方法和应用

Publications (1)

Publication Number Publication Date
PL4119573T3 true PL4119573T3 (pl) 2025-02-03

Family

ID=76981299

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22744363.7T PL4119573T3 (pl) 2021-05-13 2022-01-14 Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie

Country Status (9)

Country Link
US (1) US11787852B2 (pl)
EP (1) EP4119573B1 (pl)
JP (1) JP7411858B2 (pl)
KR (1) KR102559311B1 (pl)
CN (1) CN113185604B (pl)
ES (1) ES2998482T3 (pl)
MY (1) MY209729A (pl)
PL (1) PL4119573T3 (pl)
WO (1) WO2022237224A1 (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113185604B (zh) * 2021-05-13 2021-12-14 江苏创健医疗科技有限公司 一种重组人xvii型胶原蛋白、制备方法和应用
CN113683679B (zh) * 2021-09-15 2023-10-31 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l6t及其制备方法和用途
CN114106150B (zh) * 2021-12-03 2022-08-16 江苏创健医疗科技有限公司 重组胶原蛋白、制备方法及其应用
CN114539389B (zh) * 2022-02-22 2023-01-31 陕西巨子生物技术有限公司 重组胶原蛋白及其应用
CN114940712B (zh) * 2022-06-01 2023-12-26 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN115197301B (zh) * 2022-06-10 2024-07-16 北京师范大学 用于胞内钙信号检测及相关药物筛选的钙指示工具及其应用
CN114805551B (zh) * 2022-06-28 2022-09-13 华熙生物科技股份有限公司 一种重组iii型胶原蛋白及其制备方法
CN116478274B (zh) * 2022-07-19 2023-12-15 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN116082493B (zh) * 2022-08-10 2023-11-07 江苏创健医疗科技股份有限公司 高稳定性重组胶原蛋白、构建方法及其应用
CN117143223B (zh) * 2022-08-23 2024-03-08 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN115154356B (zh) * 2022-09-07 2022-12-06 广州集妍化妆品科技有限公司 一组胶原蛋白组合在制备抗衰老产品中的应用以及包括其的外用化妆品
CN115960209B (zh) 2022-09-29 2023-08-18 广东省禾基生物科技有限公司 一种重组人源化胶原蛋白及其应用
CN116375847B (zh) * 2022-10-26 2025-06-13 江苏创健医疗科技股份有限公司 酵母重组xvii型人源化胶原蛋白及其制备方法
CN115960211B (zh) * 2022-12-23 2023-11-21 江苏创健医疗科技股份有限公司 一种重组人源ⅵ型胶原蛋白及其制备方法和应用
CN115948441B (zh) * 2023-01-09 2025-09-23 西安交通大学 一种重组人源ⅲ型胶原蛋白及其表达体系与应用
CN115944571B (zh) * 2023-01-10 2024-04-02 河北纳科生物科技有限公司 一种促头发生长和修护发根的精华喷雾及其制备方法
CN116286914B (zh) * 2023-03-17 2024-04-16 南京斯拜科生物科技股份有限公司 一种跨膜蛋白复合体基因及其在生物发酵制备重组类人胶原蛋白中的应用
CN116218864B (zh) * 2023-04-10 2024-01-09 山东多美康生物医药有限公司 一种重组Ⅲ型人源化胶原蛋白α1及其表达载体和应用
CN116751282B (zh) * 2023-05-17 2024-07-12 博汇美萃生物工程技术(广东)有限公司 一种重组ⅹⅶ人源化胶原蛋白及其制备方法和应用
CN116640205B (zh) * 2023-05-26 2024-12-17 浙江诸暨聚源生物技术有限公司 重组xvii型胶原蛋白及其表达菌株
CN116655808B (zh) * 2023-06-01 2024-02-06 江苏创健医疗科技股份有限公司 梯度分子量重组胶原蛋白及其制备方法和应用
CN116640231B (zh) * 2023-06-09 2024-03-26 广州暨南大学医药生物技术研究开发中心有限公司 一种重组人源化17型胶原多肽及其制备方法
CN116813749B (zh) * 2023-06-13 2024-01-30 广州启点生物科技有限公司 一种重组人源化iii型胶原蛋白及其制备方法和应用
CN117230103B (zh) * 2023-09-25 2024-04-19 爱光生物医药(南昌)有限公司 17型人源化胶原蛋白及其蛋白支架、填充材料及应用
CN117598945A (zh) * 2023-10-18 2024-02-27 科丝美诗(中国)化妆品有限公司 一种用于敏感皮肤的抗衰组合物及其制备方法和应用
CN117736305B (zh) * 2023-11-01 2025-03-11 西安巨子生物基因技术股份有限公司 一种新的i型重组胶原蛋白、其生产方法及用途
CN119462898A (zh) * 2023-12-05 2025-02-18 北京华熙荣熙生物技术研究有限公司 一种具有三螺旋结构的重组xvii型胶原蛋白及其应用
CN117843763A (zh) * 2024-01-08 2024-04-09 山西锦波生物医药股份有限公司 生物合成人体结构性材料xvii型胶原蛋白的方法
CN117986353B (zh) * 2024-02-02 2024-08-30 西安巨子生物基因技术股份有限公司 重组人xvii型胶原蛋白、其制备方法及应用
CN117866077B (zh) * 2024-03-13 2024-05-28 北京未名拾光生物技术有限公司 重组xvii型胶原蛋白及其表达体系
CN118221802B (zh) * 2024-04-19 2025-11-07 西安巨子生物基因技术股份有限公司 一种促生发的重组xvii型胶原蛋白及其制备方法和应用
CN118909092A (zh) * 2024-04-29 2024-11-08 山西锦波生物医药股份有限公司 人体结构性材料xx型胶原蛋白及其生物合成方法
CN118240066B (zh) * 2024-05-20 2024-08-13 深圳粒影生物科技有限公司 一种具有三螺旋结构的重组ⅹⅶ型胶原蛋白及其应用
CN118388634B (zh) * 2024-06-12 2025-03-25 山东美瑞生物技术有限公司 一种重组人源ⅵ+xvⅱ胶原蛋白及其制备方法
CN118580338B (zh) * 2024-06-12 2025-06-06 西安巨子生物基因技术股份有限公司 一种具有增发护发作用的重组人xvii型胶原蛋白及其应用
CN118324899B (zh) * 2024-06-13 2024-08-20 江苏亨瑞生物医药科技有限公司 一种重组xvii型人源化胶原蛋白、制备方法及其应用
CN118530338B (zh) * 2024-06-17 2025-06-10 西安巨子生物基因技术股份有限公司 具有促毛囊生长作用的重组人xvii型胶原蛋白及其应用
CN118845524B (zh) * 2024-07-10 2025-05-13 广州小姿电子商务有限公司 一种淡纹紧致三重活性胶原组合物及其制备方法和应用
CN119345158B (zh) * 2024-10-09 2025-10-17 常州大学 硫缩酮键修饰的17型胶原蛋白多巴胺载药纳米粒复合微针贴片及其制备方法和应用
CN119264242A (zh) * 2024-10-11 2025-01-07 常州泰美瑞生物科技有限公司 一种重组xvii型胶原蛋白及其制备方法和应用
CN118955691B (zh) * 2024-10-21 2025-01-28 杭州凯曼健康科技有限公司 重组人源化xvii型胶原蛋白及其制备方法和应用
CN119462893A (zh) * 2024-10-31 2025-02-18 山东丰金美业科技有限公司 一种高活性重组xvii型胶原蛋白及其快速制备方法与应用
CN119504982B (zh) * 2024-12-16 2025-08-01 浙江诸暨聚源生物技术有限公司 重组人源化xvii型胶原蛋白及其表达载体和基因工程菌
CN119751646B (zh) * 2024-12-31 2025-12-02 江苏创健医疗科技股份有限公司 高稳定性的重组ⅹⅶ型胶原蛋白及其构建方法和应用
CN119798413A (zh) * 2024-12-31 2025-04-11 西安巨子生物基因技术股份有限公司 重组人xvii型胶原蛋白、其制备方法及应用
CN119798414A (zh) * 2024-12-31 2025-04-11 西安巨子生物基因技术股份有限公司 重组人xxiii型胶原蛋白、其生产方法及用途
CN119978110B (zh) * 2025-04-15 2025-08-05 广州市暨源生物科技有限公司 一种具有透皮效果的重组17型胶原蛋白及其制备方法和应用
CN120818046B (zh) * 2025-09-19 2025-12-05 浙江崇山生物制品有限公司 一种合成xvii型人源化胶原蛋白及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702948A (en) * 1995-02-02 1997-12-30 The Trustees Of The University Of Pennsylvania Saccular collagen and compositions and methods for making and using the same
WO1997038710A1 (en) 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
WO2003087343A1 (en) * 2002-04-11 2003-10-23 Fibrogen, Inc. Production of stable collagens
WO2010071938A1 (en) 2008-12-24 2010-07-01 Commonwealth Scientific And Industrial Research Organisation Novel collagen constructs
CN103102407B (zh) 2013-01-29 2014-04-30 李鹏 基因重组人胶原蛋白
CN111363029B (zh) 2018-12-25 2022-07-12 江苏江山聚源生物技术有限公司 重组人源ⅲ型胶原蛋白、表达菌株及其构建方法
CN110029111A (zh) * 2019-01-30 2019-07-19 江苏悦智生物医药有限公司 毕赤酵母生产重组人源ⅱ型胶原蛋白单链的方法
EP3965797A1 (en) * 2019-05-08 2022-03-16 AstraZeneca AB Compositions for skin and wounds and methods of use thereof
CN110845603B (zh) * 2019-10-31 2021-07-02 山西锦波生物医药股份有限公司 人胶原蛋白17型多肽、其生产方法和用途
CN113185604B (zh) 2021-05-13 2021-12-14 江苏创健医疗科技有限公司 一种重组人xvii型胶原蛋白、制备方法和应用

Also Published As

Publication number Publication date
WO2022237224A1 (zh) 2022-11-17
US20230119018A1 (en) 2023-04-20
EP4119573A4 (en) 2023-09-06
MY209729A (en) 2025-07-31
JP7411858B2 (ja) 2024-01-12
EP4119573C0 (en) 2024-09-04
KR102559311B1 (ko) 2023-07-25
CN113185604A (zh) 2021-07-30
EP4119573B1 (en) 2024-09-04
ES2998482T3 (en) 2025-02-20
US11787852B2 (en) 2023-10-17
KR20220155565A (ko) 2022-11-23
JP2023521531A (ja) 2023-05-25
EP4119573A1 (en) 2023-01-18
CN113185604B (zh) 2021-12-14

Similar Documents

Publication Publication Date Title
PL4119573T3 (pl) Rekombinowany ludzki kolagen typu XVII, metoda jego przygotowania oraz zastosowanie
GB202407559D0 (en) Recombinant collagen, preparation method therefor and application thereof
IL304804A (en) Attach a bioactive substance, a method for its preparation and use
SI4053160T1 (sl) Humani kolagen 17-tip polipeptid, postopek njegove proizvodnje in njegova uporaba
ZA202204100B (en) Pyridine oxynitride, preparation method therefor and use thereof
EP3620474A4 (en) HUMAN FIBROBLASTS GROWTH FACTOR 21 (HFGF21) FUSION PROTEIN, METHOD OF PREPARATION AND USE
EP4317177A4 (en) Trimeric S-RBD Protein Vaccine Against the Novel Coronavirus, its Preparation Method and Use
EP4062897A4 (en) HAIR CARE COMPOSITION AND METHOD FOR ITS PRODUCTION
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
EP4223137A4 (en) WHEY PROTEIN COMPOSITION AND PRODUCTION METHOD AND USE THEREOF
ZA202101260B (en) Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof
GB2621531B (en) Sintering-resistant material, preparation method therefor and application thereof
IL285368A (en) Protein-based hydrogel
GB201904794D0 (en) Molecular sieve and preparation method
GB2626658B (en) Composition, method and use
IL313659A (en) Electrode, its use and method of preparation
GB202107977D0 (en) Method, composition and use
ZA201908568B (en) Meal replacement shake, preparation method and application thereof
IL275186A (en) Human antibodies against grp94 and uses
GB2627873B (en) Composition, method and use
HK40121296A (zh) 生物活性物偶联物及其制备方法和用途
ZA202108329B (en) Ceramsite and preparation and method thereof
GB2616084B (en) Zeolite-like material, and preparation method and use thereof
GB202405920D0 (en) Medical bioactive glass, preparation method therefor, and application thereof
EP4116410A4 (en) RECOMBINANT BCG, PREPARATION METHOD THEREFOR AND ASSOCIATED APPLICATION